US measles vaccine trust hits historic low as health officials warn of crisis risk

A new Reuters-Ipsos poll has documented a sharp decline in American confidence in measles vaccines, marking the lowest point of public trust in the shot in recent memory. The finding arrives as schools across the country prepare to reopen, a moment when health officials typically see vaccination rates climb and when the risk of disease spread among unvaccinated children becomes most acute.

The measles vaccine has long been one of public health's clearest success stories. The disease, which once killed hundreds of Americans annually and left survivors deaf or brain-damaged, was declared eliminated from the United States in 2000 after a sustained vaccination campaign. But that achievement now faces genuine jeopardy. The erosion of confidence documented by the poll reflects a broader pattern of vaccine hesitancy that has taken root across American communities over the past several years, driven by misinformation, political polarization, and a generation of parents who have never witnessed measles in their own lives.

Health officials are sounding alarms about the consequences. Measles is extraordinarily contagious—a single infected person can spread the virus to as many as twelve others in an unvaccinated population. The disease is not merely uncomfortable; it can trigger pneumonia, encephalitis, and permanent neurological damage. Vulnerable populations face the highest stakes. Seniors, whose immune systems have weakened with age, face severe complications if exposed. Infants too young to receive their first vaccine dose depend entirely on the immunity of those around them. Children with certain medical conditions cannot be vaccinated at all and rely on community protection.

The timing of this trust collapse creates particular urgency. As students return to classrooms, they will spend hours in close quarters with peers from dozens of households. A single unvaccinated child carrying measles can ignite an outbreak that spreads through a school, then into the broader community. South Carolina has already flagged the specific danger to its elderly population, warning that dropping vaccination rates among younger residents threatens the health of seniors who may have waning immunity or underlying conditions that make them vulnerable.

Health officials are intensifying their messaging as the school year begins, urging parents to ensure their children are protected. The measles vaccine is safe, effective, and has been administered to hundreds of millions of people worldwide. Two doses provide immunity in roughly 97 percent of recipients. Yet the poll data suggests that public messaging alone may no longer be sufficient to reverse the trend. The decline in trust reflects something deeper than simple lack of information—it reflects a fracturing of the shared belief in institutions and expertise that once made vaccination campaigns straightforward.

What happens next will depend partly on whether health officials can rebuild confidence before measles finds its way back into American schools. The disease has not disappeared globally; it circulates in many countries and can be imported by travelers. Without sufficient vaccination rates to maintain herd immunity—typically around 95 percent for measles—the conditions for a resurgence are already taking shape. The question is no longer whether measles could return to the United States, but whether public health will be able to mount an effective response when it does.